Drugs and biologicals
Ended Awarded Last action
- Contract number
- HHSN26300071
- Awardee
-
New England Biolabs, Inc. UEI EDKJNT8DADG8
- Awarding agency
-
Office of the Director
National Institutes of Health, Department of Health and Human Services
- Obligated
- $5,819
Award facts
- Contract value 49% obligated
-
- $5,818.50 Current, with exercised options
- $11,838.00 Potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325414 Biological Product (except Diagnostic) Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Not Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Ipswich, MA 01938, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | -$201 | |
| Original award | $6,020 |
About this award
This federal contract award was made by the Office of the Director to New England Biolabs, Inc., a for-profit manufacturer of molecular biology products, for the delivery of DRUGS AND BIOLOGICALS. The award has a ceiling value of $11,838.00 and is a Blanket Purchase Agreement (BPA) call order with a firm fixed price. The place of performance is Ipswich, Massachusetts. This award is part of a larger $10,000,000 BPA with the National Institutes of Health (NIH) Office of Logistics and Acquisition Operations that is effective from January 22, 2024, through January 31, 2026. Under this BPA, various NIH components, including the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) and the National Institute of Child Health and Human Development (NICHD), have placed task orders with New England Biolabs for essential molecular biology products used in genomics research, infectious disease studies, and other critical biomedical investigations. The contract does not have a set-aside designation.
Quick answers
Who was awarded contract HHSN26300071?
HHSN26300071 was awarded to New England Biolabs, Inc. by Office of the Director (National Institutes of Health) on September 9, 2014.
How much is contract HHSN26300071 worth?
The government has obligated $5,819 on HHSN26300071. Its potential value, with all options, is $11,838.
Is contract HHSN26300071 an order under another contract?
Yes. HHSN26300071 is a BPA call under HHSN263201100018B, a blanket purchase agreement.
Was contract HHSN26300071 competed?
The extent of competition for HHSN26300071 was not competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award